NFKB1 and viral infectious disease: Furthermore, the expression of proteins involved in the LPS-activated NF-κB and MAPK signaling pathways was effectively inhibited by this combination therapy [94].Paeoniflorin demonstrates significant efficacy in combating viral infections and acute lung injury through multiple mechanisms.